Effect of macrophage ApoE on atherosclerosis in LDL-receptor deficient mice

被引:7
作者
Tennert, Carsten
Teupser, Daniel
Mueller, Marc A.
Wilfert, Wolfgang
Renner-Mueller, Ingrid
Stein, Olga
Stein, YechezkIel
Sippel, Albrecht E.
Wolf, Eckhard
Thiery, Joachim
机构
[1] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04103 Leipzig, Germany
[2] Univ Munich, Gene Ctr, Inst Mol Animal Breeding & Biotechnol, D-81377 Munich, Germany
[3] Hadassah Univ Hosp, Div Med, Lipid Res Lab, IL-91120 Jerusalem, Israel
[4] Univ Freiburg, Inst Biol 3, D-79104 Freiburg, Germany
关键词
macrophages; apolipoprotein E; atherosclerosis; Transgenic; mouse;
D O I
10.1016/j.bbrc.2007.07.067
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apolipoprotein E (ApoE) plays an important role in the development of atherosclerosis. Previous studies provide evidence for an atheroprotective role of ApoE in mouse models on the ApoE deficient (ApoE-/-) background. However, it is not clear whether this is also true on the LDL-receptor deficient (LDLR-/-) background. Transgenic mice carrying hApoE coding sequences in a chicken lysozyme expression cassette were generated. Transgene expression was directed into macrophages, expressing low levels of hApoE. Expression of the hApoE transgene was not sufficient to correct hypercholesterolemia. However, lesion area at the brachiocephalic artery (BCA) was significantly reduced (-72%) in female hApoE transgenic mice on the LDLR-/- background. This was associated with increased cholesterol efflux in macrophages of transgenic animals on the ApoE-/- background. We conclude that over-expression of ApoE in macrophages might be useful as a therapeutic principle for the prevention of atherosclerosis. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:574 / 579
页数:6
相关论文
共 26 条
[1]   MACROPHAGE-SPECIFIC EXPRESSION OF HUMAN APOLIPOPROTEIN-E REDUCES ATHEROSCLEROSIS IN HYPERCHOLESTEROLEMIC APOLIPOPROTEIN E-NULL MICE [J].
BELLOSTA, S ;
MAHLEY, RW ;
SANAN, DA ;
MURATA, J ;
NEWLAND, DL ;
TAYLOR, JM ;
PITAS, RE .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) :2170-2179
[2]  
Boisvert WA, 1999, J LIPID RES, V40, P806
[3]   EVOLUTION OF GENE-REGULATION AS REVEALED BY DIFFERENTIAL REGULATION OF THE CHICKEN LYSOZYME TRANSGENE AND THE ENDOGENOUS MOUSE LYSOZYME GENE IN MOUSE MACROPHAGES [J].
BONIFER, C ;
BOSCH, FX ;
FAUST, N ;
SCHUHMANN, A ;
SIPPEL, AE .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 226 (01) :227-235
[4]   TISSUE SPECIFIC AND POSITION INDEPENDENT EXPRESSION OF THE COMPLETE GENE DOMAIN FOR CHICKEN LYSOZYME IN TRANSGENIC MICE [J].
BONIFER, C ;
VIDAL, M ;
GROSVELD, F ;
SIPPEL, AE .
EMBO JOURNAL, 1990, 9 (09) :2843-2848
[5]   Apolipoprotein E and atherosclerosis [J].
Curtiss, LK ;
Boisvert, WA .
CURRENT OPINION IN LIPIDOLOGY, 2000, 11 (03) :243-251
[6]  
Daugherty A, 2001, J LIPID RES, V42, P1049
[7]   Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages [J].
Fazio, S ;
Babaev, VR ;
Murray, AB ;
Hasty, AH ;
Carter, KJ ;
Gleaves, LA ;
Atkinson, JB ;
Linton, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) :4647-4652
[8]   TYPE-III HYPERLIPOPROTEINEMIA ASSOCIATED WITH APOLIPOPROTEIN-E DEFICIENCY [J].
GHISELLI, G ;
SCHAEFER, EJ ;
GASCON, P ;
BREWER, HB .
SCIENCE, 1981, 214 (4526) :1239-1241
[9]   The key role of apolipoprotein E in atherosclerosis [J].
Greenow, K ;
Pearce, NJ ;
Ramji, DP .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (05) :329-342
[10]  
HARA H, 1991, J BIOL CHEM, V266, P3080